ADCETRIS – Brentuximab Vedotin uses, dose and side effects
Adcetris contains the active substance brentuximab vedotin , an anti-cancer agent consisting of monoclonal antibodies bound to a substance which is intended to kill cancer cells. This substance is delivered to cancer cells by the monoclonal antibody . A monoclonal antibody is a protein that recognizes certain cancer cells.
Read More